Kymera Therapeutics, Inc.

NasdaqGM:KYMR Stock Report

Market Cap: US$2.0b

Kymera Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:KYMR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Mar 24SellUS$400,462Atlas Venture L.P.Company10,008US$41.51
13 Mar 24SellUS$439,939Atlas Venture L.P.Company10,268US$43.42
04 Mar 24SellUS$164,664Bruce JacobsIndividual3,934US$43.26
04 Mar 24SellUS$139,967Jared GollobIndividual3,344US$43.26
04 Jan 24SellUS$74,416Ellen ChiniaraIndividual3,295US$22.58
03 Nov 23BuyUS$5,301,325BVF Partners L.P.Company414,105US$14.07
01 Jun 23SellUS$95,132,561Vertex Pharmaceuticals IncorporatedCompany3,533,899US$26.92

Insider Trading Volume

Insider Buying: KYMR insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of KYMR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,7530.0045%
General Public441,3710.722%
Individual Insiders827,7571.35%
VC/PE Firms5,377,3628.8%
Hedge Funds14,825,82624.3%
Institutions39,636,60964.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.2%.


Top Shareholders

Top 25 shareholders own 87.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.82%
T. Rowe Price Group, Inc.
5,999,256US$200.9m-9.54%0.02%
9.81%
Baker Bros. Advisors LP
5,995,928US$200.8m0%2.72%
8.8%
Atlas Venture L.P.
5,377,362US$180.1m-8.21%19.92%
8.27%
BVF Partners L.P.
5,054,898US$169.3m-2.07%4.47%
7.88%
Wellington Management Group LLP
4,815,558US$161.2m-0.16%0.03%
6.54%
The Vanguard Group, Inc.
3,997,564US$133.9m1.84%no data
6.18%
Avoro Capital Advisors LLC
3,775,000US$126.4m-2.08%1.96%
5.84%
BlackRock, Inc.
3,566,611US$119.4m6.22%no data
4.14%
Artal Group S.A.
2,530,735US$84.7m40.2%2.68%
3.1%
State Street Global Advisors, Inc.
1,894,279US$63.4m-4.61%no data
2.98%
Redmile Group, LLC
1,823,956US$61.1m-2.38%2.71%
2.49%
Rock Springs Capital Management LP
1,522,238US$51.0m1.19%1.51%
1.44%
Aquilo Capital Management, LLC
881,337US$29.5m12.7%20.76%
1.44%
Geode Capital Management, LLC
880,515US$29.5m5.55%no data
1.01%
Deer Management Company, LLC
615,895US$20.6m0%1.82%
1.01%
Nello Mainolfi
615,570US$20.6m1.48%no data
0.96%
Goldman Sachs Group, Investment Banking and Securities Investments
588,559US$19.7m358%0.01%
0.87%
FMR LLC
534,600US$17.9m-38.6%no data
0.87%
Dimensional Fund Advisors LP
533,723US$17.9m-18.5%no data
0.82%
Norges Bank Investment Management
504,083US$16.9m127%no data
0.78%
UBS Asset Management AG
476,963US$16.0m35.3%no data
0.76%
Massachusetts Financial Services Company
462,675US$15.5m-0.19%no data
0.72%
JP Morgan Asset Management
438,183US$14.7m-21.6%no data
0.72%
Schonfeld Strategic Advisors LLC
437,633US$14.7m0%0.12%
0.66%
Morgan Stanley, Investment Banking and Brokerage Investments
404,497US$13.5m30.3%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.